ApconiX Target Safety Assessments Archives
ApconiX Is Offering an Industrial Immunotoxicology Research/Development Internship ApconiX is a team of non-clinical safety experts formed in 2015 by three scientists with the drive and ambition to create a world-renowned company. Our services include target safety assessments, ion channel screening and project toxicology. We are a growing company, [...]
ApconiX Is Recruiting Target Safety Biologists (Associate /Senior Scientist) The closing date for this job vacancy has passed. Please visit our Come and Join Us page for current vacancies. If you believe you have the skills and experience and would like to become part of our team please send your speculative CV to [...]
ApconiX Is Recruiting Experienced Target Safety Biologists (Principal Scientist) The closing date for this job vacancy has passed. Please visit our Come and Join Us page for current vacancies. If you believe you have the skills and experience and would like to become part of our team please send your speculative CV to [...]
ApconiX Welcomes Michelle Blissett ApconiX is delighted to welcome Michelle Blissett who joins the Acuity Target Safety Assessment team working with Professor Ruth Roberts and Dr James Sidaway. With almost 20 years devoted to preclinical toxicology, Michelle has developed an excellent ability to conduct extensive literature searches, interrogating, analysing [...]
ApconiX Welcomes William Humfrey ApconiX is delighted to welcome William Humfrey who joins the Acuity Target Safety Assessment team working with Professor Ruth Roberts and Dr James Sidaway. Will studied for an integrated master’s degree in biomedical science at the University of Sheffield where he gained understanding of human [...]
Platelet Function Testing in Target Safety Assessments Adverse Findings Adverse findings in non-clinical safety/toxicity testing continue to be a major reason for failure and/or complexity in drug projects. Since primary target-related toxicity plays a role in a significant proportion of these failures, an in-depth assessment of potential adverse consequences [...]
Unravelling Some Mechanistic and Clinical Aspects of Immunological Drug-Drug Interactions Dr Sean Hammond, as a member of an interdisciplinary team, has recently published the third of a series of papers seeking to unravel mechanistic and clinical aspects of the immunological drug-drug interactions that occur with immune checkpoint inhibitors. Immunotoxicology [...]
ApconiX Is Recruiting a Target Safety Biologist The closing date for this job vacancy has passed. Please visit our Come and Join Us page for current vacancies. If you believe you have the skills and experience and would like to become part of our team please send your speculative CV to careers@apconix.com ApconiX [...]
SOT 2022 - Continuous Education Course Professor Ruth Roberts will be presenting at the SOT 2022 Continuous Education (CE) Programme Course in the session entitled ‘Safety Evaluation Strategies in Drug Discovery: From Target Assessment to Identification of Drug Candidates’. This CE course will take a chronological look at drug [...]
Acuity Target Safety Assessments: Knowledge is Power A thorough understanding of potential target-related effects is crucial to making the right choices in drug discovery. Experienced project toxicologists extract and interpret data from mouse knockouts, human gene mutations and known effects of modulators to determine the potential consequences of target inhibition or [...]
